1. Home
  2. FFIC vs TRDA Comparison

FFIC vs TRDA Comparison

Compare FFIC & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$15.96

Market Cap

510.6M

Sector

Finance

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.70

Market Cap

500.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
TRDA
Founded
1929
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
510.6M
500.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
FFIC
TRDA
Price
$15.96
$6.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$16.80
$21.00
AVG Volume (30 Days)
193.4K
603.9K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
5.50%
N/A
EPS Growth
151.43
N/A
EPS
0.17
N/A
Revenue
$7,455,000.00
$25,421,000.00
Revenue This Year
$14.57
$39.97
Revenue Next Year
$6.64
$50.80
P/E Ratio
$93.76
N/A
Revenue Growth
7.31
N/A
52 Week Low
$11.13
$4.93
52 Week High
$17.79
$16.45

Technical Indicators

Market Signals
Indicator
FFIC
TRDA
Relative Strength Index (RSI) 52.99 33.80
Support Level $15.56 $5.58
Resistance Level $16.58 $6.90
Average True Range (ATR) 0.32 0.81
MACD 0.01 -0.28
Stochastic Oscillator 63.36 9.70

Price Performance

Historical Comparison
FFIC
TRDA

About FFIC Flushing Financial Corporation

Flushing Financial Corp is a bank holding company. Through its subsidiary, the company is engaged in attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, mainly in originations and purchases of multi-family residential properties loans, commercial business loans, commercial real estate mortgage loans and, to a lesser extent, one-to-four family loans (focusing on mixed-use properties, which are properties that contain both residential dwelling units and commercial units). It also operates an internet branch, under the brands of iGObanking.com and BankPurely. The company operates as a single unit, a community bank.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: